Today: 20 May 2026
Browse Category

NYSE:XLE 10 December 2025 - 7 February 2026

Energy stocks face Tuesday test as oil steadies and geopolitics shifts

Energy stocks face Tuesday test as oil steadies and geopolitics shifts

U.S. energy shares will reopen Tuesday after a holiday pause, with crude prices steady and Brent near $64 a barrel. The S&P 500 Energy sector ended last week up 0.21%, outpacing the broader market in 2026. Traders await U.S. petroleum inventory data Thursday and monitor U.S.-Europe tensions over Greenland. Markets watch for any break in oil’s tight price range at Tuesday’s open.
19 January 2026
·
Energy Stocks Today: Oil Slides Into Year-End, LNG Oversupply Fears Grow, and What to Watch Before Monday’s Open

Energy Stocks Today: Oil Slides Into Year-End, LNG Oversupply Fears Grow, and What to Watch Before Monday’s Open

Oil prices fell sharply Friday, with Brent settling at $60.64 a barrel and WTI at $56.74, both down over 2% amid renewed supply glut concerns. The S&P 500 Energy sector closed down 0.28% but remains up 3.74% for the year. U.S. petroleum inventory data is scheduled for release Monday, earlier than usual. Trading volumes were thin, and energy ETFs like XLE stayed rangebound.
28 December 2025
Energy Stocks Outlook: Oil Slides on Oversupply Fears, LNG Bubble Warnings Mount, and What Investors Should Watch Before Monday

Energy Stocks Outlook: Oil Slides on Oversupply Fears, LNG Bubble Warnings Mount, and What Investors Should Watch Before Monday

Energy stocks fell Friday, with the S&P 500 Energy sector down 0.28% and the XLE ETF closing at $44.20. Brent crude settled at $60.64 a barrel, WTI at $56.74, both dropping over 2.5% on oversupply concerns. The IEA forecasts supply growth outpacing demand into 2026. Investors await U.S. energy data and developments in Ukraine and Venezuela.
27 December 2025
·
Energy Stocks After the Bell: XLE Extends Gains as Oil Steadies Around $58 – December 10, 2025 Market Wrap

Energy Stocks After the Bell: XLE Extends Gains as Oil Steadies Around $58 – December 10, 2025 Market Wrap

Energy stocks edged higher Wednesday, with the Energy Select Sector SPDR Fund (XLE) up 0.26% to $45.82, even as crude prices slipped. WTI crude settled at $57.93 per barrel, down 0.55%, and Brent closed near $61.5–62, off 0.6%. Major U.S. equity indices were flat. Traders weighed oversupply concerns and Ukraine peace talks ahead of the Fed’s rate decision.
10 December 2025
··

Stock Market Today

  • SpaceX IPO Filing Could Propel Elon Musk to Trillionaire Status
    May 20, 2026, 5:46 PM EDT. SpaceX's recent S-1 filing signals a potential initial public offering (IPO) that could surpass the 2020 record set by Saudi Aramco as the largest IPO in history. The deal is expected to significantly increase the valuation of SpaceX, potentially making CEO Elon Musk a trillionaire. This move highlights the growing investor interest in private spaceflight companies and the expanding market for space exploration-related ventures.

Latest articles

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

20 May 2026
Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
Go toTop